HRA003627
Title:
Discovered biomarkers for predicting esophageal squamous precancerous lesions to cancer transition
Release date:
2023-07-06
Description:
Esophageal squamous precancerous lesions (ESPL) are the precursors of esophageal squamous cell carcinoma (ESCC) including low-grade (LGIN) and high-grade (HGIN) intraepithelial neoplasia. Because of lack molecular biomarkers, which ESPL will eventually develop to ESCC and thus should be treated is not well defined. We performed spatial whole-transcriptome atlas (WTA) analysis to discover biomarkers for predicting risks of ESCC when people are diagnosed with ESPL even at LGIN stage.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
esophagus squamous cell carcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
China-US Hormel Cancer Institute
Contact person:
Li Xiang
Email:
xli@hci-cn.org
Description:
DAC for the project "Discovered biomarkers for predicting esophageal squamous precancerous lesions to cancer transition"
Individuals & samples
Submitter:   Li Xiang / xli@hci-cn.org
Organization:   China-US (Henan) Hormel Cancer Institute
Submission date:   2022-12-13
Requests:   6